bullish

Syra Health

SYRA: Reiterates Revenue Guidance Up 64%-100% Y/Y, Diversifying, Growing Pipeline

156 Views14 May 2024 22:00
Issuer-paid
The company attributed the strong topline to investments in technology and personnel made in recent quarters to support expected growth. The...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 16-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Zacks Small Cap Research
Research Coverage on Small and Micro-Cap Companies
Zacks Small Cap Research
Equity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • SYRA: Reiterates Revenue Guidance Up 64%-100% Y/Y, Diversifying, Growing Pipeline
    14 May 2024
x